AbbVie (ABBV) - News Mentions

Sign up to add (ABBV) to your portfolio and access more historical data.

2 100%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Johnson & Johnson
Johnson & Johnson
JNJ		 1 0%
Eli Lilly and Company
Eli Lilly and Company
LLY		 0 0%
Pfizer
Pfizer
PFE		 2 33.3%
Astrazeneca
Astrazeneca
AZN		 2 0%
TherapeuticsMD
TherapeuticsMD
TXMD		 0 0%
AbbVie Inc. (NYSE:ABBV) Receives $205.70 Average Price Target from Analysts
December 20
AbbVie (NYSE:ABBV) Trading Down 0.5% After Insider Selling
December 19
Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals
December 19
AbbVie (NYSE:ABBV) Stock Price Expected to Rise, Piper Sandler Analyst Says
December 19
Piper Sandler Companies Reaffirms Overweight Rating for AbbVie (NYSE:ABBV)
December 19
AbbVie Inc. stock underperforms Thursday when compared to competitors
December 19
AbbVie's atogepant and onabotulinumtoxinA receive strong recommendations in the newly updated Canadian Headache Society (CHS) Migraine Prevention Guideline
December 18
Is AbbVie Inc. (ABBV) the Safest Dividend Stock to Invest In Now?
December 18
AbbVie Inc. stock underperforms Wednesday when compared to competitors
December 18
AbbVie (NYSE:ABBV) versus BriaCell Therapeutics (OTCMKTS:BCTXF) Head to Head Contrast
December 17
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
December 17
AbbVie’s tavapadon achieves positive topline results in Phase III TEMPO-2 trial
December 17
AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back?
December 17
AbbVie Inc. stock outperforms competitors on strong trading day
December 17
AbbVie Enters Oversold Territory
December 16
AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors
December 16

Month over Month

Est. daily news mentions.

Nov 2024 1
Oct 2024 2
Sep 2024 1
Aug 2024 1
Jul 2024 1

How often is AbbVie mentioned in the news?

AbbVie was mentioned an estimated 2 times in online prominent news articles yesterday.

Analyzing News Mentions, how is AbbVie performing compared to its industry peers?

AbbVie underperforms its industry peers when it comes to News Mentions, ranking in the 33rd percentile.

Has there been an increase or decrease in news mentions of AbbVie in the last month?

Yes, there has been an increase in news mentions. AbbVie's was mentioned 100% more times in the news the yesterday compared to the same day last month.

Why is it important to track news mentions for AbbVie?

By monitoring mentions in the news for AbbVie, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of AbbVie, ultimately improving their investment strategies.

Sign up and get more insights on AbbVie.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact